Clinical utility of protein induced by vitamin K absence in patients with chronic hepatitis B virus infection
- PMID: 24648907
- PMCID: PMC3956828
- DOI: 10.3892/br.2012.4
Clinical utility of protein induced by vitamin K absence in patients with chronic hepatitis B virus infection
Abstract
Hepatitis B virus (HBV) is a leading cause of hepatocellular carcinoma (HCC). α-fetoprotein (AFP) is a common tumor marker for the diagnosis of HCC, although not for protein induced by the absence of vitamin K or antagonist-II (PIVKA-II). The present study aimed to evaluate the role of PIVKA-II in the diagnosis of HCC in HBV-infected Vietnamese patients. A total of 166 consecutive HBV-infected Vietnamese patients were enrolled, including 41 HCC, 43 liver cirrhosis (LC), 26 chronic hepatitis (CH) and 56 asymptomatic carriers (ASC). AFP was examined using ELISA, while PIVKA-II was analyzed using Eitest PIVKA-II. The cut-off level of AFP and PIVKA-II was 20 ng/ml and 40 mAU/ml, respectively. Although the markers, AFP (344±356 ng/ml) and PIVKA-II (16,200±25,386 mAU/ml), were the highest in the HCC groups, only PIVKA-II in HCC was significantly higher compared to the other groups (P<0.001). The univariate analysis demonstrated that age over 50, male, genotype C, AFP and PIVKA-II were risk factors of LC and HCC. Results of the receiver operating characteristics (ROC) analysis showed that PIVKA-II was more sensitive to HCC compared to AFP. Moreover, PIVKA-II was strongly correlated with the portal venous thrombosis in HCC, as opposed to AFP. Results of the multivariate analysis demonstrated that PIVKA-II was the strongest independent risk factor of LC and HCC. In conclusion, PIVKA-II is likely to be a better marker for the diagnosis of HCC in chronic HBV-infected Vietnamese patients.
Keywords: Vietnam; hepatitis B virus; hepatocellular carcinoma; protein induced by vitamin K absence or antagonist-II.
Figures


Similar articles
-
Diagnostic value of prothrombin induced by the absence of vitamin K or antagonist-II (PIVKA-II) for early stage HBV related hepatocellular carcinoma.Infect Agent Cancer. 2017 Aug 23;12:47. doi: 10.1186/s13027-017-0153-6. eCollection 2017. Infect Agent Cancer. 2017. PMID: 28852419 Free PMC article.
-
Evaluation of Serum GDF15, AFP, and PIVKA-II as Diagnostic Markers for HBV-Associated Hepatocellular Carcinoma.Lab Med. 2021 Jul 1;52(4):381-389. doi: 10.1093/labmed/lmaa089. Lab Med. 2021. PMID: 33159511
-
The combination of PIVKA-II and AFP improves the detection accuracy for HCC in HBV caucasian cirrhotics on long-term oral therapy.Liver Int. 2020 Aug;40(8):1987-1996. doi: 10.1111/liv.14475. Epub 2020 May 23. Liver Int. 2020. PMID: 32301212
-
Protein induced by vitamin K absence or antagonist-II versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: A systematic review with meta-analysis.Hepatobiliary Pancreat Dis Int. 2018 Dec;17(6):487-495. doi: 10.1016/j.hbpd.2018.09.009. Epub 2018 Sep 15. Hepatobiliary Pancreat Dis Int. 2018. PMID: 30257796
-
Usefulness of the novel oncofetal antigen glypican-3 for diagnosis of hepatocellular carcinoma and melanoma.BioDrugs. 2005;19(2):71-7. doi: 10.2165/00063030-200519020-00001. BioDrugs. 2005. PMID: 15807627 Review.
Cited by
-
Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular carcinoma diagnosing: an update meta-analysis and validation study.Oncotarget. 2017 Aug 7;8(52):90390-90401. doi: 10.18632/oncotarget.20153. eCollection 2017 Oct 27. Oncotarget. 2017. PMID: 29163838 Free PMC article.
References
-
- Truong BX, Bang NV. The prevalence of HBV infection, HCV infection, co-infection of HBV/HCV and HBV genotype in the border region between Vietnam and China in Batxat district, Laocai province. Vietnam J Med Res. 2009;64:52–59.
-
- Nguyen VT, McLaws ML, Dore GJ. Highly endemic hepatitis B infection in rural Vietnam. J Gastroenterol Hepatol. 2007;22:2093–2100. - PubMed
-
- Hipgrave DB, Nguyen TV, Vu MH, Hoang TL, Do TD, Tran NT, Jolley D, Maynard JE, Biggs BA. Hepatitis B infection in rural Vietnam and the implications for a national program of infant immunization. Am J Trop Med Hyg. 2003;69:288–294. - PubMed
-
- Truong BX, Yano Y, Seo Y, et al. Variations in the core promoter/pre-core region in HBV genotype C in Japanese and Northern Vietnamese patients. J Med Virol. 2007;79:1293–1304. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous